CLINICAL TRIALS PROFILE FOR FLUOCINONIDE
✉ Email this page to a colleague
All Clinical Trials for FLUOCINONIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00297011 ↗ | Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis | Completed | GlaxoSmithKline | Phase 2 | 2004-09-01 | A randomized study comparing the combination of valacyclovir and temovate gel (clobetasol gel) versus placebo for the treatment of recurrent herpes labialis (cold sores). |
NCT00297011 ↗ | Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis | Completed | University of Utah | Phase 2 | 2004-09-01 | A randomized study comparing the combination of valacyclovir and temovate gel (clobetasol gel) versus placebo for the treatment of recurrent herpes labialis (cold sores). |
NCT00667589 ↗ | Sorafenib-induced Hand- Foot Skin Reaction Treatment | Terminated | Bayer | Phase 2 | 2008-06-01 | The purpose of this study is to evaluate treatments for a rash caused by sorafenib. |
NCT00667589 ↗ | Sorafenib-induced Hand- Foot Skin Reaction Treatment | Terminated | Northwestern University | Phase 2 | 2008-06-01 | The purpose of this study is to evaluate treatments for a rash caused by sorafenib. |
NCT00819507 ↗ | VANOS Cream and Skin Barrier Function | Completed | Medicis Pharmaceutical Corporation | Phase 4 | 2009-01-01 | The purpose of this study is to determine the effect of short-term therapy using "VANOS Cream," a super-potent topical steroid cream on skin barrier function in patients with atopic dermatitis. This cream is already approved for this indication, but the investigators will further examine its effects on the skin barrier. This cream is a novel formulation of fluocinonide designed to enhance compliance with a cream base, but have the skin barrier repair properties of an ointment. |
NCT00819507 ↗ | VANOS Cream and Skin Barrier Function | Completed | Oregon Health and Science University | Phase 4 | 2009-01-01 | The purpose of this study is to determine the effect of short-term therapy using "VANOS Cream," a super-potent topical steroid cream on skin barrier function in patients with atopic dermatitis. This cream is already approved for this indication, but the investigators will further examine its effects on the skin barrier. This cream is a novel formulation of fluocinonide designed to enhance compliance with a cream base, but have the skin barrier repair properties of an ointment. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for FLUOCINONIDE
Condition Name
Clinical Trial Locations for FLUOCINONIDE
Trials by Country
Clinical Trial Progress for FLUOCINONIDE
Clinical Trial Phase
Clinical Trial Sponsors for FLUOCINONIDE
Sponsor Name